Location History:
- Montramaud, FR (2016)
- Montarnaud, FR (2011 - 2019)
Company Filing History:
14 out of 100 
4 out of 5,081 
3 out of 279 
Years Active: 2011-2019
Title: Claire Pierra: Innovator in Antiviral Research
Introduction
Claire Pierra is a prominent inventor based in Montarnaud, France. She has made significant contributions to the field of antiviral research, particularly in the development of nucleoside analogs for the treatment of viral infections. With a total of 14 patents to her name, her work has had a substantial impact on the medical community.
Latest Patents
Among her latest patents are innovative compounds aimed at treating HCV infections. One notable patent involves 2'-chloro nucleoside analogs, which provide methods for treating Flaviviridae infections, including HCV. These compounds can be administered alone or in combination with other antiviral agents. Another significant patent focuses on D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds, which demonstrate remarkable efficacy and bioavailability for treating HCV infections in humans.
Career Highlights
Claire Pierra has worked with notable organizations such as Idenix Pharmaceuticals, Inc. and the Centre National De La Recherche Scientifique. Her career has been marked by a commitment to advancing antiviral therapies and improving patient outcomes.
Collaborations
Throughout her career, Claire has collaborated with esteemed colleagues, including Cyril B Dousson and Dominique Surleraux. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Claire Pierra's innovative work in antiviral research has led to significant advancements in the treatment of viral infections. Her contributions continue to influence the medical field and inspire future research endeavors.